Tokyo Tape
Sign in
← Euglena

Annual report

2931.TEDINET S100QG7X
Period2022-01-01 → 2022-12-31
Filed2023-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 64
MetricValuePeriodScopeSource row
Revenue¥44.4bn2022-01-01 → 2022-12-31Cons.Net sales
Revenue¥34.4bn2020-10-01 → 2021-12-31Cons.Net sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31Cons.Operating income
Operating income−¥6.6bn2020-10-01 → 2021-12-31Cons.Operating income
Ordinary income−¥2.5bn2022-01-01 → 2022-12-31Cons.Ordinary income
Ordinary income−¥6.4bn2020-10-01 → 2021-12-31Cons.Ordinary income
Profit before tax−¥2.4bn2022-01-01 → 2022-12-31Cons.Income before income taxes
Profit before tax−¥6.7bn2020-10-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥5.0bn2020-10-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income−¥2.7bn2022-01-01 → 2022-12-31Cons.Profit loss
Net income−¥5.8bn2020-10-01 → 2021-12-31Cons.Profit loss
Total assets¥57.3bnat 2022-12-31Cons.Assets
Total assets¥61.0bnat 2021-12-31Cons.Assets
Total liabilities¥37.9bnat 2022-12-31Cons.Liabilities
Total liabilities¥40.4bnat 2021-12-31Cons.Liabilities
Net assets / equity¥19.4bnat 2022-12-31Cons.Net assets
Net assets / equity¥20.6bnat 2021-12-31Cons.Net assets
Cash and deposits¥10.0bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥9.9bnat 2021-12-31Cons.Cash and deposits
Cash & equivalents¥9.8bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.8bnat 2021-12-31Cons.Cash and cash equivalents
Operating cash flow¥924m2022-01-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.4bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow¥1.2bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥10.3bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2022-01-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥12.1bn2020-10-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-23.832022-01-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.072020-10-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥167.34at 2022-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥181.35at 2021-12-31Cons.Net assets per share (5-year summary)
Equity ratio33.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio33.0%at 2021-12-31Cons.Equity to asset ratio (5-year summary)
Employees865at 2022-12-31Cons.Number of employees
Employees883at 2021-12-31Cons.Number of employees
Revenue¥6.5bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥9.5bn2020-10-01 → 2021-12-31StandaloneNet sales
Operating income−¥3.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥3.4bn2020-10-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥2.2bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥2.6bn2020-10-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥2.6bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥2.7bn2020-10-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥2.7bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥2.4bn2020-10-01 → 2021-12-31StandaloneProfit loss
Total assets¥26.7bnat 2022-12-31StandaloneAssets
Total assets¥27.8bnat 2021-12-31StandaloneAssets
Total liabilities¥5.2bnat 2022-12-31StandaloneLiabilities
Total liabilities¥5.5bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥21.5bnat 2022-12-31StandaloneNet assets
Net assets / equity¥22.3bnat 2021-12-31StandaloneNet assets
Cash and deposits¥2.9bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.9bnat 2021-12-31StandaloneCash and deposits
EPS (basic)¥-23.92022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-22.942020-10-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥186.11at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥197.18at 2021-12-31StandaloneNet assets per share (5-year summary)
Equity ratio78.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio78.8%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued113,105,455at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued111,161,886at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Employees250at 2022-12-31StandaloneNumber of employees
Employees212at 2021-12-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥1m
Reconciling Itemsreconcilingdepreciation2022-01-01 → 2022-12-31¥50m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥3.4bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥1.7bn
Biofuel Businessreportable segmentcapex2022-01-01 → 2022-12-31¥22m
Biofuel Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥49m
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Biofuel Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥262m
Biofuel Businessreportable segmentsegment assetsat 2022-12-31¥947m
Biofuel Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥789m
Health Care Businessreportable segmentcapex2022-01-01 → 2022-12-31¥406m
Health Care Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥2.2bn
Health Care Businessreportable segmentemployeesat 2022-12-31655 pure
Health Care Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥41.6bn
Health Care Businessreportable segmentsegment assetsat 2022-12-31¥49.6bn
Health Care Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥638m
Others Businessreportable segmentcapex2022-01-01 → 2022-12-31¥48m
Others Businessreportable segmentdepreciation2022-01-01 → 2022-12-31¥34m
Others Businessreportable segmentemployeesat 2022-12-31113 pure
Others Businessreportable segmentrevenue2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentrevenue external2022-01-01 → 2022-12-31¥2.5bn
Others Businessreportable segmentsegment assetsat 2022-12-31¥3.3bn
Others Businessreportable segmentsegment profit2022-01-01 → 2022-12-31−¥325m
—segment totalcapex2022-01-01 → 2022-12-31¥477m
—segment totaldepreciation2022-01-01 → 2022-12-31¥2.3bn
—segment totalrevenue2022-01-01 → 2022-12-31¥44.4bn
—segment totalrevenue external2022-01-01 → 2022-12-31¥44.4bn
—segment totalsegment assetsat 2022-12-31¥53.9bn
—segment totalsegment profit2022-01-01 → 2022-12-31−¥1.8bn
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-12-31¥31m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-12-31¥94m
Reconciling Itemsreconcilingsegment assetsat 2021-12-31¥5.7bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-12-31−¥2.2bn
Biofuel Businessreportable segmentcapex2020-10-01 → 2021-12-31¥37m
Biofuel Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥110m
Biofuel Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥47m
Biofuel Businessreportable segmentsegment assetsat 2021-12-31¥602m
Biofuel Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥1.2bn
Health Care Businessreportable segmentcapex2020-10-01 → 2021-12-31¥387m
Health Care Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥1.5bn
Health Care Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥33.7bn
Health Care Businessreportable segmentsegment assetsat 2021-12-31¥52.1bn
Health Care Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥2.8bn
Others Businessreportable segmentcapex2020-10-01 → 2021-12-31¥54m
Others Businessreportable segmentdepreciation2020-10-01 → 2021-12-31¥14m
Others Businessreportable segmentrevenue2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentrevenue external2020-10-01 → 2021-12-31¥627m
Others Businessreportable segmentsegment assetsat 2021-12-31¥2.6bn
Others Businessreportable segmentsegment profit2020-10-01 → 2021-12-31−¥373m
—segment totalcapex2020-10-01 → 2021-12-31¥479m
—segment totaldepreciation2020-10-01 → 2021-12-31¥1.6bn
—segment totalrevenue2020-10-01 → 2021-12-31¥34.4bn
—segment totalrevenue external2020-10-01 → 2021-12-31¥34.4bn
—segment totalsegment assetsat 2021-12-31¥55.3bn
—segment totalsegment profit2020-10-01 → 2021-12-31−¥4.4bn
Biofuel Businessreportable segmentemployeesat 2022-12-3143 pure
Health Care Businessreportable segmentemployeesat 2022-12-31127 pure
Others Businessreportable segmentemployeesat 2022-12-3125 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,625
ItemContextValueUnit
Average number of temporary workersPrior2YearInstant_NonConsolidatedMember46
Average number of temporary workersPrior1YearInstant_NonConsolidatedMember44
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember40
Total shareholder returnPrior4YearInstant_NonConsolidatedMember0.739
Total shareholder returnPrior3YearInstant_NonConsolidatedMember0.763
Total shareholder returnPrior2YearInstant_NonConsolidatedMember0.743
Total shareholder returnPrior1YearInstant_NonConsolidatedMember0.600
Total shareholder returnCurrentYearInstant_NonConsolidatedMember0.828
Total return on share price indexPrior4YearInstant_NonConsolidatedMember1.085
Total return on share price indexPrior3YearInstant_NonConsolidatedMember0.948
Total return on share price indexPrior2YearInstant_NonConsolidatedMember0.971
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.190
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.130
Number of employeesCurrentYearInstant_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember655
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember177
Number of employeesCurrentYearInstant_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember43
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember5
Number of employeesCurrentYearInstant_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember113
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember10
Number of employeesCurrentYearInstant_CorporateSharedMember54
Average number of temporary workersCurrentYearInstant_CorporateSharedMember13
Number of employeesCurrentYearInstant865
Average number of temporary workersCurrentYearInstant205
Number of employeesCurrentYearInstant_NonConsolidatedMember250
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember40
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember41
Average age months information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember0
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember4
Average length of service months information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember10
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember6683000JPY
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember127
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember19
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember43
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember5
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember25
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember3
Number of employeesCurrentYearInstant_NonConsolidatedMember_CorporateSharedMember55
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_CorporateSharedMember13
Number of employeesCurrentYearInstant_NonConsolidatedMember250
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember40
Research and development expenses research and development activitiesCurrentYearDuration1480000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration478000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E27054-000HealthCareBusinessReportableSegmentsMember406000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E27054-000BiofuelBusinessReportableSegmentsMember22000000JPY
Capital expenditures overview of capital expenditures etcCurrentYearDuration_jpcrp030000-asr_E27054-000OthersBusinessReportableSegmentsMember48000000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember113105455
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember116313955
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant113105455
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant116313955
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 22 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution partial
statement vs summary · net assetsconsolidated 2021-12-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2020-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2020-10-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenueconsolidated 2020-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass